Valneva SE has appointed two leading vaccine experts to its scientific advisory board as it continues development of candidate vaccines against Lyme disease and chikungunya. New board member Norman Baylor, formerly with the US Food and Drug Administration, is currently chief executive of Biologics Consulting Group Inc. In his regulatory career he has evaluated many new vaccines including those for human papillomavirus and influenza. Dr Baylor is an expert advisor to the World Health Organization on several global vaccine initiatives. The second new board member is George Siber, an adjunct professor of medicine at Johns Hopkins University, US. He has more than 40 years of experience developing new vaccines including multiple paediatric vaccines against pneumococcus, meningococcus and respiratory syncytial virus.
Valneva announced the appointment on 13 November 2019.
